Evidence map›Paper›PMID 40831250›Full record

ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2025

Active Learning-Assisted Exploration of [PO

Lincan Fang, Ruoxue Peng, Luping Xia, Gui-Lin Zhuang

Abstract read
In one paragraph

Article in Advanced science (Weinheim, Baden-Wurttemberg, Germany), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Active Learning-Assisted Exploration of [POAdvanced science (Weinheim, Baden-Wurttemberg, Germany) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Lincan FangKey Laboratory of Functional Molecular Solids Ministry of Education, College of Chemistry and Materials Science, Anhui Normal University, Wuhu, Anhui, 241002, P.R. China.
Ruoxue PengKey Laboratory of Functional Molecular Solids Ministry of Education, College of Chemistry and Materials Science, Anhui Normal University, Wuhu, Anhui, 241002, P.R. China.
Luping XiaKey Laboratory of Functional Molecular Solids Ministry of Education, College of Chemistry and Materials Science, Anhui Normal University, Wuhu, Anhui, 241002, P.R. China.
Gui-Lin ZhuangKey Laboratory of Functional Molecular Solids Ministry of Education, College of Chemistry and Materials Science, Anhui Normal University, Wuhu, Anhui, 241002, P.R. China.ORCID https://orcid.org/0000-0002-4763-7397

Funding

National Natural Science Foundation of China 22072135National Natural Science Foundation of China 22471004National Natural Science Foundation of China 92461305Zhejiang Provincial Natural Science Foundation of China LTGY23B010001
6 · The paper itself

Abstract

Alzheimer's disease (AD), involving amyloid-β (Aβ) aggregation, has potential therapeutic modulators in polyoxometalates (POMs) like [PMo

Indexed as

Alzheimer DiseaseAmyloid beta-PeptidesTungsten CompoundsHumansHydrogen BondingPolyoxometalatesAmyloid beta-Peptidespolyoxometalate IPolyoxometalatesTungsten Compoundsactive learningalzheimerbayesian optimizationDFTPOM

Identifiers

PMID40831250
PMCPMC12622557

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.